| Entry |
|
|---|
| Name |
Levotofisopam (USAN/INN) |
|---|
| Formula |
C22H26N2O4
|
|---|
| Exact mass |
382.1893
|
|---|
| Mol weight |
382.4528
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
DG01914 Anxiolytics, benzodiazepine derivatives
|
|---|
| Efficacy |
Antianxiety |
|---|
| Comment |
Benzodiazepine derivative
See Tofisopam [DR: D01254]
Autonomic instability
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
D04721 Levotofisopam
DG01914 Anxiolytics, benzodiazepine derivatives
D04721 Levotofisopam
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D04721 Levotofisopam (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 28
1 C2y C 10.2652 -15.3773
2 C8y C 9.4208 -14.2647
3 C8y C 9.7569 -12.9042
4 C1y C 11.0214 -12.3245
5 N2x N 11.6748 -15.4026
6 C2y C 12.2783 -12.9485
7 N2x N 12.5656 -14.3210
8 C8x C 8.7470 -11.9331
9 C8y C 7.4014 -12.3223
10 C8y C 7.0653 -13.6828
11 C8x C 8.0751 -14.6536
12 C1a C 13.3253 -12.0115
13 O2a O 6.3922 -11.3519
14 C1a C 5.0473 -11.7407
15 C1a C 4.7112 -13.1012
16 O2a O 5.7203 -14.0715
17 C1b C 11.0432 -10.9210
18 C1a C 12.2796 -10.2325
19 C8y C 9.5436 -16.5769
20 C8x C 8.1436 -16.5769
21 C8y C 7.4436 -17.7894
22 C8y C 8.1436 -19.0018
23 C8x C 9.5436 -19.0018
24 C8x C 10.2436 -17.7894
25 O2a O 6.0436 -17.7894
26 C1a C 5.3436 -19.0019
27 C1a C 6.0436 -20.2143
28 O2a O 7.4436 -20.2142
BOND 30
1 3 4 1
2 1 5 2
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 2
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 6 12 1
14 9 13 1
15 13 14 1
16 15 16 1
17 10 16 1
18 4 17 1 #Down
19 17 18 1
20 1 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 22 23 1
25 23 24 2
26 19 24 1
27 21 25 1
28 25 26 1
29 27 28 1
30 22 28 1
|
|---|
